Terranueva Announces Changes to Its Management Team and Board of Directors
MONTREAL, April 27, 2021 (GLOBE NEWSWIRE) -- The Board of Directors of Terranueva Corporation (CSE: TEQ) ("Terranueva" or the "Company")...
Day: April 27, 2021
Golden Leaf Reports Record 2020 Revenues of $21.9 Million and First Adjusted EBITDA1 Positive Quarter
Six months of positive cash flow from operations. Turnaround complete and focused on growth and optimization.PORTLAND, Ore., April 27, 2021...
NeuBase Therapeutics to Present at the B. Riley Securities’ Virtual Neuroscience Conference
PITTSBURGH, April 27, 2021 (GLOBE NEWSWIRE) -- NeuBase Therapeutics, Inc. (Nasdaq: NBSE) (“NeuBase”), a biotechnology company accelerating the genetic revolution...
Wesana Health Adds Israel Mirsky as Chief Strategy Officer
CHICAGO, April 27, 2021 (GLOBE NEWSWIRE) -- Wesana Health Inc. (“Wesana” or the “Company”), an emerging life sciences company focused...
Daré Bioscience Announces Ovaprene®, a Novel Investigational Hormone-Free Contraceptive, Poster Presentation at the 2021 Annual Clinical and Scientific Meeting of the American College of Obstetricians and Gynecologists
SAN DIEGO, April 27, 2021 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ:DARE), a leader in women’s health innovation, today announced that data...
Equillium Announces Three Abstracts Accepted for Presentation at the 104th Annual Meeting of the American Association of Immunologists
Presentations highlight the pathogenic role of the CD6-ALCAM pathway, the immunologic impact of modulating this pathway with itolizumab, and pharmacodynamic...
Jounce Therapeutics to Announce First Quarter 2021 Financial Results and Host Conference Call on Tuesday, May 4, 2021
CAMBRIDGE, Mass., April 27, 2021 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (NASDAQ: JNCE), a clinical-stage company focused on the discovery...
Newly Released Data on Three PGHD Patients Treated with LUM-201 in Prior Phase 2 Study To Be Presented in Lumos Pharma Key Opinion Leader Webinar
Virtual KOL Event is scheduled for Today, April 27th @ 10:30 AM ETAUSTIN, Texas, April 27, 2021 (GLOBE NEWSWIRE) --...
Bright Minds Biosciences Appoints Industry Experts for Key Roles and Expands Scientific Advisory Team
Strengthens therapeutic development programs with key hires in Pharmacology and ToxicologyVANCOUVER, British Columbia, April 27, 2021 (GLOBE NEWSWIRE) -- Bright...
Pyxis Oncology Presents Preclinical Data and Details on Antibody-Drug Conjugate Candidates Supporting Therapeutic Potential
Pyxis Oncology to host webcast with Key Opinion Leaders (KOLs) on April 27, 2021 at 1:00pm ETCAMBRIDGE, Mass., April 27,...
Zogenix Launches Global Access Program for FINTEPLA® (Fenfluramine) Oral Solution
FINTEPLA is approved in the U.S. and European Union as an add-on therapy for the treatment of seizures associated with...
VistaGen Therapeutics Announces Appointment of Joanne Curley, Ph.D. to its Board of Directors
Dr. Curley brings extensive pharmaceutical industry experience in product development, commercialization and operations as VistaGen advances late-stage development of its...
T2 Biosystems Announces Meta-analysis of Controlled Studies in Peer-Reviewed Medical Journal Highlighting the Benefits of T2MR Technology Compared to Blood Culture
Study concludes the utilization of T2 Magnetic Resonance (T2MR®) provides faster time to detection, faster time to targeted therapy, and...
Sotera Health Announces Q1 2021 Earnings Release Date and Participation in the RBC Capital Markets Global Healthcare Conference
CLEVELAND, April 27, 2021 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization...
Arch Therapeutics to Present AC5® Advanced Wound System at 2021 Symposium on Advanced Wound Care (SAWC)
Additional case studies support the broad potential of AC5® Advanced Wound System in chronic and non-healing woundsFRAMINGHAM, Mass., April 27,...
Afya Announces a $150 Million Investment from the SoftBank Latin America Fund
NOVA LIMA, Brazil and MINAS GERAIS, Brazil, April 27, 2021 (GLOBE NEWSWIRE) -- Afya Limited, or Afya (Nasdaq: AFYA), the...
Matinas BioPharma to Webcast Conference Call Discussing First Quarter 2021 Financial and Operational Results on May 10, 2021
BEDMINSTER, N.J., April 27, 2021 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE AMER: MTNB), a clinical-stage biopharmaceutical company focused on...
Brickell Biotech Completes Patient Enrollment in U.S. Phase 3 Pivotal Cardigan I Study of Sofpironium Bromide Gel, 15% for the Treatment of Primary Axillary Hyperhidrosis
Phase 3 Pivotal Cardigan II study exceeds 50% enrollment- - -Topline results for Phase 3 Pivotal Cardigan I and Cardigan...
InMed Pharmaceuticals Announces Voluntary Delisting from TSX
All common shares will continue to be listed and tradable on the NasdaqVANCOUVER, British Columbia, April 27, 2021 (GLOBE NEWSWIRE)...
Antios Therapeutics Continues Building Experienced Executive Team with Appointments of Katie Laessig, M.D., as SVP, Global Regulatory Affairs and Karen Fusaro as SVP, Clinical Operations
Responsible for managing clinical development and the regulatory processes for ATI-2173, an ASPIN, which is in development as part of...